AMRA Medical

View 1 open job Website LinkedIn Careers Page

Focus: AMRA Medical is a Sweden-based biotech company specializing in MRI-based body-composition analysis technology for clinical research and drug development. Founded in 2010, the company operates at the intersection of diagnostics and therapeutic validation with a focus on liver disease and metabolic disorders.

Infectious Diseases

Profile data last refreshed 10h ago · AI intelligence enriched 2w ago

Open Jobs

Should You Work at AMRA Medical?

AI assessment

AMRA Medical is a specialized pre-revenue biotech with differentiated technology but limited hiring activity and unknown funding/runway — suitable for early-stage risk-tolerant researchers but not for candidates seeking stability or rapid career growth.

Why Work Here

Specialized niche technology (MRI body-composition analysis) with multiple active research collaborations across liver disease, sarcopenia, and metabolic dysfunction indications

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

5 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Relevance of Sarcopenia in Advanced Liver Disease

Liver Cirrhosis

N/A

Clinical Trials (1)

NCT05502198Relevance of Sarcopenia in Advanced Liver Disease

N/A

Help build intelligence for AMRA Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage company founded 2010 offering potential for hands-on involvement in research partnerships and clinical validation studies

Hiring in both Commercial and Development roles suggests early commercialization phase with growth trajectory

Watch Out For

Only 2 active job openings and no public financial data (revenue, funding, cash position) raise transparency and hiring velocity concerns
Pre-revenue biotech status with pipeline programs in research/investigational phases (no Phase 1+ clinical trials) indicates lengthy runway before commercialization and job security

Generated by Claude from AMRA Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Co

Liver Cirrhoses

N/A

Clinical Trials (1)

NCT07291141A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis

N/A

Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)

FSHD

N/A

MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study

MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease

N/A

Clinical Trials (1)

NCT07312136MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study

N/A

MAsS

Sarcopenia in Liver Disease